GABA Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: oral GABA and sleep physiology

Nootropic Compounds compound PowderCapsule verified

Also known as: Gamma-Aminobutyric Acid, gamma-aminobutyric acid

Quick Facts

Reference Sizes
100 g, 250 g, 500 g, 500 mg capsules, 750 mg capsules
Storage
Store tightly closed in a cool dry place
Solubility
Freely soluble in water

Catalog Description

Gamma-aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the mammalian CNS, acting on GABA-A and GABA-B receptors. Orally supplemented GABA is generally considered to cross the blood-brain barrier poorly, so proposed relaxation effects from oral GABA supplements may act via peripheral/enteric nervous system pathways rather than direct CNS GABA-receptor activation - a mechanistic point of ongoing debate in the literature.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life
A clinically useful oral supplement half-life is not established; peripheral metabolism is rapid and human blood-brain-barrier penetration remains unresolved
Onset
Small trials assess acute stress markers or sleep after dosing but results are inconsistent
Administration Routes (Research)
Oral

Reported Research Effects

Reported Research Side Effects

Data source: Systematic review, randomized trial, USP safety review, and current market checks

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Route-Specific Research Protocols

Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.

Label / guideline Human study Community only Preclinical only Not established
Oral Human study only

300 mg once daily

Frequency / timing
30-60 minutes before sleep
Duration / setting
Four weeks
Technique
Oral
Evidence
Human study protocol

Context: randomized insomnia-symptom trial PMCID PMC6031986

Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.

Route safety: Research-study protocol only; it is not an approved or individualized instruction and should not be extrapolated to another route.

Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.

Research Interactions

Flagged Avoid / Caution Combinations (Research)

Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.

Research Notes

A systematic review found limited evidence for stress and very limited evidence for sleep. Community claims about reliable CNS effects or supplement stacking exceed the evidence.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

Systematic review of oral GABA for stress and sleep — PubMed Central (NIH)
https://pmc.ncbi.nlm.nih.gov/articles/PMC7527439/
Randomized fermented-GABA sleep trial — PubMed Central (NIH)
https://pmc.ncbi.nlm.nih.gov/articles/PMC6031986/
USP safety review of GABA — PubMed Central (NIH)
https://pmc.ncbi.nlm.nih.gov/articles/PMC8399837/

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Articles

Published articles on this site that mention GABA or one of its catalog aliases.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top